Viewing Study NCT02400567


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-02-20 @ 6:20 PM
Study NCT ID: NCT02400567
Status: COMPLETED
Last Update Posted: 2022-03-15
First Post: 2014-08-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women
Sponsor: UNICANCER
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoadjuvant Operable Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Luminal View
None Post menopausal View
None Breast conservation View
None Neoadjuvant View